Article

ASHP's Pharmacy Residency Match Meets Continued Demand for Training

ASHP’s 2017 Match concluded today, as 4,504 individuals matched with more than 2,140 pharmacy residency programs across the country.

PRESS RELEASE

ASHP’s 2017 Match concluded today, as 4,504 individuals matched with more than 2,140 pharmacy residency programs across the country. The Match was conducted in two phases to meet the needs of the rapidly growing number of pharmacists and student pharmacists seeking residencies as well as residency programs seeking applicants. Over the last five years, residency positions have increased by 1,224 positions, or 36%.

“The 2017 Match results show that applicants and positions continue to grow as the demand for residency training grows in the healthcare market.” said Janet A. Silvester, Pharm.D., M.B.A., FASHP, Vice President, ASHP Accreditation Services Office. “The two-phase Match provides for a more stable and structured recruitment process.”

Now in its second year, ASHP’s Phase II of the Match gives applicants who did not match in Phase I another opportunity to connect with a postgraduate training program. Phase II of the Match resulted in 304 positions filled, in addition to the 3,831 positions filled during Phase I.

The 2017 Post-Match Scramble will begin with submission of applications on April 13 at noon EDT. ASHP recommends that programs make their offers to candidates beginning on April 19. ASHP will also host a Virtual Career Fair on Wednesday, April 19, for those applicants who did not match with a residency program.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com